Parkinson’s Disease

Collaborators from the Fixel Institute and MBI will pilot a novel, low-cost intervention to improve Parkinson’s symptoms.

A team led by Cara Croft, Ph.D., has demonstrated a novel method to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. Learn more:

A review by Dr. David Vaillancourt, a member of the MBI's executive committee, was recently featured on the cover of the journal Movement Disorders.

Study demonstrates that additional proteins misfold in the presence of neurodegenerative disease pathologies.

In a recent editorial in JAMA Neurology, a group of neurologists at at The Fixel Center for Neurological Diseases at UF Health discuss medication trends for Parkinson's disease dementia.

The Institute for Human and Machine Cognition's podcast, STEM-Talk, features Michael Okun, M.D., who talks about the complexity and treatment of Parkinson's disease.

MBI members discuss how the service and science hub specialty care model is working at the Fixel Center.

Following Alan Alda’s announcement that he has Parkinson’s, Dr. Michael Okun explains in an article for The Conversation that it’s a livable disease, but there’s a critical shortage of doctors to treat it.

Michael Okun, M.D., UF neurology chair and medical director of the National Parkinson's Foundation, recently commented in a news story released by South Africa's health24 on the link between diabetes and Parkinson's disease.

Adolfo Ramirez-Zamora, M.D., associate professor of neurology, provided his expertise in an article in Inside Science.